Sarah McClelland is Professor in Cancer Genomics and Cancer Cell Biology at the Barts Cancer Institute, Queen Mary University of London and deputy Centre lead for Cancer Genomics and Computational Biology.

Sarah studied Biochemistry and obtained her PhD in Biochemistry from the University of Bristol. Her lab aims to understand the mechanisms that underlie numerical and structural chromosome aberrations in cancer at a molecular level, which also involves understanding how normal cells replicate and segregate their genomes.